Marketable Securities	9 Months Ended
Sep. 30, 2023
Marketable Securities
Marketable Securities	Note 4 – Marketable Securities Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Realized and unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months ended September 30, 2023 and 2022, we purchased $0 and $0 of marketable securities, respectively, and we sold $0 and $15,000 of marketable equity securities, respectively. During the nine months ended September 30, 2023 and 2022, we purchased $0 and $6.0 million of marketable securities, respectively, and we sold $0 and $15,000 of marketable equity securities, respectively. During the three months ended September 30, 2023 and 2022, gross realized and unrealized gains were $0 and $2,000, respectively, and gross realized and unrealized losses were $0 and $0, respectively. During the nine months ended September 30, 2023 and 2022, gross realized and unrealized gains were $0 and $2,000, respectively, and gross realized and unrealized losses were $0 and $0, respectively. As of September 30, 2023, we had no marketable equity securities.

Marketable Securities

9 Months Ended

Sep. 30, 2023

Note 4 – Marketable Securities

Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Realized and unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months ended September 30, 2023 and 2022, we purchased $0 and $0 of marketable securities, respectively, and we sold $0 and $15,000 of marketable equity securities, respectively. During the nine months ended September 30, 2023 and 2022, we purchased $0 and $6.0 million of marketable securities, respectively, and we sold $0 and $15,000 of marketable equity securities, respectively. During the three months ended September 30, 2023 and 2022, gross realized and unrealized gains were $0 and $2,000, respectively, and gross realized and unrealized losses were $0 and $0, respectively. During the nine months ended September 30, 2023 and 2022, gross realized and unrealized gains were $0 and $2,000, respectively, and gross realized and unrealized losses were $0 and $0, respectively. As of September 30, 2023, we had no marketable equity securities.